NASDAQ · Biotechnology

Viking Therapeutics, Inc. (VKTX) Stock

$28.51 +2.81% NASDAQ: VKTX Healthcare

Valuation

MetricValue
Price$28.51
Market Cap$3.33B
P/E Ratio-6.83
P/B Ratio9.03
P/S Ratio0.00
EPS (TTM)$-3.19
52-Week High$43.15
52-Week Low$21.23
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-94.56%
ROA-102.47%
ROCE-135.85%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio9.30

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-56.0M$-70.0M$-101.0M$-151.0M$-393.0M
Net Profit$-55.0M$-69.0M$-86.0M$-110.0M$-360.0M
EPS$-0.70$-0.88$-0.91$-1.01$-3.19
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$211.0M$169.0M$368.0M$908.0M$716.0M
Total Liabilities$9.0M$23.0M$20.0M$28.0M$77.0M
Cash$26.0M$37.0M$56.0M$27.0M$166.0M
Borrowings$0$2.0M$1.0M$1.0M$0

Latest News

Here Is Why Viking Therapeutics (VKTX) is Amongst The Most Affordable Biotech Stocks to Buy Insider Monkey · Jul 15, 2026 As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 CNW Group · Jul 15, 2026 Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks · Jul 10, 2026 Novo Nordisk (NYSE:NVO) Updates Wegovy Label In Singapore With STEP UP Data Simply Wall St. · Jul 9, 2026 3 High Growth GLP-1 Biotech Winners to Buy in July 24/7 Wall St. · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-48.0M$-48.0M$-73.0M$-88.0M$-279.0M
Investing Cash Flow$38.0M$55.0M$-179.0M$-553.0M$341.0M
Financing Cash Flow$-1.0M$6.0M$2.0M$15.0M$74.0M
Net Cash Flow$-3.0M$10.0M$19.0M$-29.0M$139.0M
Free Cash Flow$-48.0M$-48.0M$-73.0M$-88.0M$-279.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.08
EV / EBITDA-6.72
FCF Yield-11.28%
Quick Ratio4.72
Interest Coverage-70002.62
Return 1Y16.61%
Return 3Y132.20%
Return 5Y444.78%

Ownership

Insiders Held2.79%
Institutions Held64.47%
Institutions Float Held66.32%
Institutional HolderSharesReport Date
Blackrock Inc.6,880,2902026-03-31
FMR, LLC6,024,7532026-03-31
Vanguard Capital Management LLC5,012,5022026-03-31
Vanguard Portfolio Management LLC4,464,2982026-03-31
Two Sigma Investments, LP4,432,1422026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Viking Therapeutics, Inc.

Viking Therapeutics, Inc. (VKTX) stock trades at $28.51 with a market capitalization of $3.33B. The stock is valued at a price-to-earnings (P/E) ratio of -6.83, price-to-book of 9.03, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $21.23 and $43.15, and currently trades 33.9% below its 52-week high.

On profitability, Viking Therapeutics, Inc. generates a return on equity (ROE) of -94.56%, return on capital employed of -135.85%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides